| Treatment |
MCAo [min] |
Animals [n] |
ΔCSI |
Infarct Size [%] |
| Data Range |
Median |
IQR |
Data Range |
Median |
IQR |
| Control |
45 |
8 |
-0.032 to 0.087 |
0.047 |
0.078 |
0.7 to 15.8 |
6.96 |
9.25 |
| 90 |
9 |
-0.143 to 0.156 |
0.055 |
0.066 |
1.1 to 17.2 |
3.23 |
6.76 |
| 5E+04 ASCs |
45 |
7 |
0.054 to 0.179 |
0.089 |
0.088 |
0.5 to 9.3 |
4.63 |
5.94 |
| 3E+05 ASCs |
45 |
6 |
0.079 to 0.136 |
0.099 |
0.034 |
1.7 to 10 |
5.86 |
3.83 |
| 90 |
6 |
0.079 to 0.143 |
0.093 |
0.046 |
1.1 to 13.1 |
6.82 |
6.43 |
| 1E+06 ASCs |
45 |
4 |
0.014 to 0.2 |
0.157 |
0.12 |
3.8 to 26.1 |
13.37 |
16.93 |
| 90 |
3 |
0.083 to 0.379 |
0.12 |
- |
4.2 to 20.6 |
19.64 |
- |
| ASC = Adipose tissue derived stem cell; ΔCSI = Difference in cell signal intensity; IQR = Interquartile range, MCAo = Middle cerebral artery occlusion |
|
